AMIX Latest Press Releases

-- October 2, 2026 --

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation Globe Newswire 8:05 AM

-- September 30, 2026 --

Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance Globe Newswire 8:30 AM

-- September 24, 2026 --

Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform Globe Newswire 8:30 AM

-- September 16, 2026 --

Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors Globe Newswire 8:30 AM

-- September 1, 2026 --

Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026 Globe Newswire 8:30 AM

-- August 26, 2026 --

Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery Globe Newswire 8:30 AM

-- August 24, 2026 --

Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules Globe Newswire 9:06 PM

-- August 12, 2026 --

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission Globe Newswire 8:15 AM

-- August 10, 2026 --

Autonomix Medical Congratulates Co-Founder & Chief Medical Officer Dr. Robert Schwartz on Receiving Prestigious 2026 Cardiovascular Tech Forum Lifetime Achievement Award Globe Newswire 8:20 AM

-- August 4, 2026 --

Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy Globe Newswire 8:15 AM

-- July 24, 2026 --

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study Globe Newswire 8:47 AM

-- July 23, 2026 --

Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform Globe Newswire 7:30 AM

-- July 15, 2026 --

Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform Globe Newswire 8:00 AM

-- July 13, 2026 --

Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules Globe Newswire 9:30 PM

Autonomix Medical Strengthens Global Intellectual Property Position with New Neural Sensing Patent Grant Globe Newswire 7:30 AM

-- June 22, 2026 --

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change Globe Newswire 8:00 AM

-- June 18, 2026 --

Autonomix Announces Reverse Stock Split Globe Newswire 4:30 PM

-- June 10, 2026 --

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology Globe Newswire 9:05 AM

-- June 4, 2026 --

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine Globe Newswire 9:05 AM

-- May 19, 2026 --

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation Globe Newswire 8:30 AM

-- May 18, 2026 --

Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation Globe Newswire 8:45 AM

Market Data Delayed 15 Minutes